EMEA (EUROPE, MIDDLE EAST AND AFRICA) ANTIVENOM MARKET 2017 FORECAST TO 2022

Feb 2018 118

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.

Scope of the Report:
This report focuses on the Antivenom in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- CSL Behring
- Merck & Co., Inc.
- BTG Plc
- Pfizer
- Haffkine Bio-Pharmaceutical Corporation
- Rare Disease Therapeutics
- Flynn Pharma
- Vins Bioproducts
- Bharat Serums and Vaccines
- Serum Biotech

Market Segment by Regions, regional analysis covers
- Europe (Germany, France, UK, Russia, Italy and Turkey)
- Middle East (Saudi Arabia, Israel, UAE and Iran)
- Africa (South Africa, Nigeria, Egypt and Algeria)

Market Segment by Type, covers
- Polyvalent antivenom
- Monovalent antivenom

Market Segment by Applications, can be divided into
- Retail Pharmacies
- Hospitals
- Others

There are 13 Chapters to deeply display the EMEA Antivenom market.

Chapter 1, to describe Antivenom Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Antivenom, with sales, revenue, and price of Antivenom, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of Antivenom, for each region, from 2012 to 2017;

Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;

Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 10, Antivenom market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 11, 12 and 13, to describe Antivenom research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source

Table of Contents

Related reports :

(Apr 18)

"The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins...

(Apr 18)

Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastro...

(Apr 18)

"Enzyme-linked immunosorbent assay (ELISA), also known as an enzyme immunoassay (EIA), is a biochemical technique used mainly in immunology ...

(Apr 18)

Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory con...

(Apr 18)

This report studies the Fertility and Pregnancy Rapid Test Kits market, pregnancy and fertility rapid tests are point of care tests used to ...

(Apr 18)

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and wors...

EMEA (EUROPE, MIDDLE EAST AND AFRICA) ANTIVENOM MARKET 2017 FORECAST TO 2022


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Healthcare market as per your needs. Get the best of Healthcare research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*